Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

GS Future Health Care Equity ETF (GDOC)

GS Future Health Care Equity ETF (GDOC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Goldman Sachs
  • Assets Under Management 21,510,900
  • Shares Outstanding, K 625
  • 60-Month Beta 0.84
  • Price/Earnings ttm 39.83
  • Annual Dividend & Yield 0.01 (0.02%)
  • Most Recent Dividend 0.006 on 12/23/24
  • Management Fee 0.75%

Price Performance

See More
Period Period Low Period High Performance
1-Month
31.59 +8.18%
on 01/02/25
34.49 -0.91%
on 01/31/25
+2.02 (+6.28%)
since 12/31/24
3-Month
31.59 +8.18%
on 01/02/25
34.75 -1.66%
on 11/08/24
+0.20 (+0.60%)
since 10/31/24
52-Week
31.59 +8.18%
on 01/02/25
37.23 -8.20%
on 08/30/24
+1.06 (+3.19%)
since 01/30/24

Most Recent Stories

More News
Goldman Sachs Thinks Mid-Cap Biotech MoonLake Could Soar Over 80%: Is Retail Watching Closely?

Oppenheimer has included MoonLake among its top biotech picks for 2025, alongside Capricor, Gilead, Kymera, Praxis, and Prothena.

GURU : 52.65 (-0.70%)
GDOC : 34.18 (-0.63%)
SBIO : 33.02 (-0.77%)
MLTX : 45.99 (-2.40%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The Goldman Sachs Future Health Care Equity ETF seeks long-term growth of capital.

See More

Key Turning Points

3rd Resistance Point 34.70
2nd Resistance Point 34.59
1st Resistance Point 34.39
Last Price 34.18
1st Support Level 34.07
2nd Support Level 33.97
3rd Support Level 33.76

See More

52-Week High 37.23
Fibonacci 61.8% 35.07
Fibonacci 50% 34.41
Last Price 34.18
Fibonacci 38.2% 33.74
52-Week Low 31.59

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar